Literature DB >> 27572973

A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.

Jacob E Lemieux1,2, Alice D Tran3, Lisa Freimark1, Stephen F Schaffner1, Heidi Goethert4, Kristian G Andersen1,5, Suzane Bazner2, Amy Li6, Graham McGrath2, Lynne Sloan7, Edouard Vannier8, Dan Milner9, Bobbi Pritt7, Eric Rosenberg2,10, Sam Telford4, Jeffrey A Bailey3,11, Pardis C Sabeti1,12.   

Abstract

Human babesiosis caused by Babesia microti is an emerging tick-borne zoonosis of increasing importance due to its rising incidence and expanding geographic range(1). Infection with this organism, an intraerythrocytic parasite of the phylum Apicomplexa, causes a febrile syndrome similar to malaria(2). Relapsing disease is common among immunocompromised and asplenic individuals(3,4) and drug resistance has recently been reported(5). To investigate the origin and genetic diversity of this parasite, we sequenced the complete genomes of 42 B. microti samples from around the world, including deep coverage of clinical infections at endemic sites in the continental USA. Samples from the continental USA segregate into a Northeast lineage and a Midwest lineage, with subsequent divergence of subpopulations along geographic lines. We identify parasite variants that associate with relapsing disease, including amino acid substitutions in the atovaquone-binding regions of cytochrome b (cytb) and the azithromycin-binding region of ribosomal protein subunit L4 (rpl4). Our results shed light on the origin, diversity and evolution of B. microti, suggest possible mechanisms for clinical relapse, and create the foundation for further research on this emerging pathogen.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572973      PMCID: PMC5563076          DOI: 10.1038/nmicrobiol.2016.79

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  45 in total

1.  Case records of the Massachusetts General Hospital. Case 6-2014. A 35-day-old boy with fever, vomiting, mottled skin, and severe anemia.

Authors:  Phoebe H Yager; Lynn M Luginbuhl; John P Dekker
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

2.  A polymorphic multigene family encoding an immunodominant protein from Babesia microti.

Authors:  M J Homer; E S Bruinsma; M J Lodes; M H Moro; S Telford; P J Krause; L D Reynolds; R Mohamath; D R Benson; R L Houghton; S G Reed; D H Persing
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Expansion of zoonotic babesiosis and reported human cases, Connecticut, 2001-2010.

Authors:  C Stafford Kirby; Scott C Williams; Louis A Magnarelli; Anuja Bharadwaj; Starr-Hope Ertel; Randall S Nelson
Journal:  J Med Entomol       Date:  2014-01       Impact factor: 2.278

4.  Human babesiosis in the United States.

Authors:  T K Ruebush; A Spielman
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

5.  Alignment of whole genomes.

Authors:  A L Delcher; S Kasif; R D Fleischmann; J Peterson; O White; S L Salzberg
Journal:  Nucleic Acids Res       Date:  1999-06-01       Impact factor: 16.971

6.  Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment.

Authors:  Aya Matsuu; Kayoko Miyamoto; Hiromi Ikadai; Shozo Okano; Seiichi Higuchi
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

7.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

8.  Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli.

Authors:  H S Chittum; W S Champney
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

9.  Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.

Authors:  Gary P Wormser; Aakanksha Prasad; Ellen Neuhaus; Samit Joshi; John Nowakowski; John Nelson; Abraham Mittleman; Maria Aguero-Rosenfeld; Jeffrey Topal; Peter J Krause
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

10.  Babesiosis Occurrence among the Elderly in the United States, as Recorded in Large Medicare Databases during 2006-2013.

Authors:  Mikhail Menis; Richard A Forshee; Sanjai Kumar; Stephen McKean; Rob Warnock; Hector S Izurieta; Rahul Gondalia; Chris Johnson; Paul D Mintz; Mark O Walderhaug; Christopher M Worrall; Jeffrey A Kelman; Steven A Anderson
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

View more
  30 in total

Review 1.  Transfusion-transmitted babesiosis: is it time to screen the blood supply?

Authors:  Andrew E Levin; Peter J Krause
Journal:  Curr Opin Hematol       Date:  2016-11       Impact factor: 3.284

Review 2.  Babesia microti: from Mice to Ticks to an Increasing Number of Highly Susceptible Humans.

Authors:  Lars F Westblade; Matthew S Simon; Blaine A Mathison; Laura A Kirkman
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

3.  Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia.

Authors:  Matthew S Simon; Lars F Westblade; Alexis Dziedziech; Joseph E Visone; Richard R Furman; Stephen G Jenkins; Audrey N Schuetz; Laura A Kirkman
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

4.  Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.

Authors:  Richard I Horowitz; Phyllis R Freeman
Journal:  Antibiotics (Basel)       Date:  2022-07-07

5.  Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.

Authors:  Neeharik Mareedu; Anna M Schotthoefer; Jason Tompkins; Matthew C Hall; Thomas R Fritsche; Holly M Frost
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 6.  Emerging Tick-Borne Diseases.

Authors:  Susan Madison-Antenucci; Laura D Kramer; Linda L Gebhardt; Elizabeth Kauffman
Journal:  Clin Microbiol Rev       Date:  2020-01-02       Impact factor: 26.132

7.  Babesia microti from humans and ticks hold a genomic signature of strong population structure in the United States.

Authors:  Giovanna Carpi; Katharine S Walter; Choukri Ben Mamoun; Peter J Krause; Andrew Kitchen; Timothy J Lepore; Ankit Dwivedi; Emmanuel Cornillot; Adalgisa Caccone; Maria A Diuk-Wasser
Journal:  BMC Genomics       Date:  2016-11-07       Impact factor: 3.969

8.  Babesia microti Aldo-keto Reductase-Like Protein Involved in Antioxidant and Anti-parasite Response.

Authors:  Qiang Huang; Jie Cao; Yongzhi Zhou; Jingwei Huang; Haiyan Gong; Houshuang Zhang; Xing-Quan Zhu; Jinlin Zhou
Journal:  Front Microbiol       Date:  2017-10-11       Impact factor: 5.640

9.  Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle.

Authors:  Joy E Chiu; Isaline Renard; Santosh George; Anasuya C Pal; P Holland Alday; Sukanya Narasimhan; Michael K Riscoe; J Stone Doggett; Choukri Ben Mamoun
Journal:  J Infect Dis       Date:  2022-01-05       Impact factor: 7.759

10.  Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions.

Authors:  Joana C Silva; Emmanuel Cornillot; Carrie McCracken; Sahar Usmani-Brown; Ankit Dwivedi; Olukemi O Ifeonu; Jonathan Crabtree; Hanzel T Gotia; Azan Z Virji; Christelle Reynes; Jacques Colinge; Vidya Kumar; Lauren Lawres; Joseph E Pazzi; Jozelyn V Pablo; Chris Hung; Jana Brancato; Priti Kumari; Joshua Orvis; Kyle Tretina; Marcus Chibucos; Sandy Ott; Lisa Sadzewicz; Naomi Sengamalay; Amol C Shetty; Qi Su; Luke Tallon; Claire M Fraser; Roger Frutos; Douglas M Molina; Peter J Krause; Choukri Ben Mamoun
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.